More than three-quarters of survey respondents were infection preventionists working in acute-care hospitals where Foley catheters are widely used.
• CAUTIs cost U.S. hospitals between $400 million and $500 million annually.
• Under the Affordable Care Act, some hospitals have already had Medicare reimbursements cut due to high CAUTI rates.
• Percentage of respondents who said Foley catheters can cause trauma to the wall or lining of the bladder — 79 percent.
• Percentage of respondents who said this trauma could in crease risk of CAUTIs — 83 percent.
• Percentage of respondents who reported their facilities were not adequately complying with recommended CAUTI reduction protocols — 54.6 percent.
• Percentage of respondents who report their administration puts a strong emphasis on CAUTI reduction — 66.7 percent.
More articles on infection control:
Infection preventionists approve 11 C. diff prevention recommendations
5 things to know about clinical pathways and quality improvement
Consumer Reports rates hospitals on infections: 9 highest, 12 lowest performing hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
